| Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers M Panagopoulou, M Karaglani, I Balgkouranidou, E Biziota, T Koukaki, ... Oncogene 38 (18), 3387-3401, 2019 | 137 | 2019 |
| Prognostic role of RASSF1A, SOX17 and Wif-1 promoter methylation status in cell-free DNA of advanced gastric cancer patients EI Karamitrousis, I Balgkouranidou, N Xenidis, K Amarantidis, E Biziota, ... Technology in cancer research & treatment 20, 1533033820973279, 2021 | 17 | 2021 |
| Real world data regarding the management of cancer-associated thrombosis N Tsoukalas, K Tsapakidis, M Galanopoulos, E Karamitrousis, ... Current opinion in oncology 32 (4), 289-294, 2020 | 7 | 2020 |
| Association between SOX17, Wif-1 and RASSF1A promoter methylation status and response to chemotherapy in patients with metastatic gastric cancer E Karamitrousis, I Balgkouranidou, N Xenidis, K Amarantidis, E Biziota, ... Clinical Chemistry and Laboratory Medicine (CCLM) 59 (2), e73-e75, 2021 | 4 | 2021 |
| Clinicopathological characteristics in women with breast cancer in extreme ages in Greece: A single centre experience H Karachalios, E Karamitrousis, P Daskalakis Forum of Clinical Oncology 12 (2), 1-7, 2022 | 1 | 2022 |
| Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance E Karamitrousis, I Balgkouranidou, N Xenidis, K Amarantidis, E Biziota, ... Forum of Clinical Oncology 12 (3), 72-76, 2021 | 1 | 2021 |
| Prognostic significance of BRCA1 and BRCA2 methylation status in circulating cell-free DNA of Pancreatic Cancer patients T Koukaki, I Balgkouranidou, E Biziota, A Karayiannakis, H Bolanaki, ... Journal of Cancer 15 (9), 2573, 2024 | | 2024 |
| A retrospective multicentric cohort study of checkpoint inhibitors‐induced pruritus with focus on management C Papageorgiou, E Lazaridou, K Lallas, K Papaioannou, V Nikolaou, ... Photodermatology, Photoimmunology & Photomedicine 39 (5), 506-511, 2023 | | 2023 |
| Cancer Heterogeneity and Biomarkers A Michas, E Karamitrousis, N Tsoukalas, M Liontos Forum of Clinical Oncology 13 (3), 1-2, 2022 | | 2022 |
| Neuro-endocrine neoplasms (NENs): The necessity of a multidisciplinary approach for achieving best clinical outcomes E Karamitrousis, M Liontos, N Tsoukalas Forum of Clinical Oncology 13 (1), 1-2, 2022 | | 2022 |
| Epigenetics and cancer - A dependence relationship E Karamitrousis, M Liontos, N Tsoukalas Forum of Clinical Oncology 12 (3), 1-2, 2022 | | 2022 |
| Metabolomics in oncology – A fascinating travel into the mechanisms of metabolic disturbances during carcinogenesis E Karamitrousis, M Liontos, N Tsoukalas Forum of Clinical Oncology 12 (1), 1-2, 2021 | | 2021 |
| Rare cancers are common: time to act. M Liontos, E Karamitrousis, N Tsoukalas, I Boukovinas Forum of Clinical Oncology 11 (3), 1-2, 2021 | | 2021 |
| Predicting Lymph Nodal Metastases in Patients with Appendiceal Cancers: Invited Brief Commentary on a Paper Entitled: A Nomogram for Predicting Lymph Nodal Metastases in … N Tsoukalas, M Galanopoulos, K Tsapakidis, E Karamitrousis, ... Journal of Investigative Surgery, 2020 | | 2020 |
| Cancer Patients and Oncology Clinical Practice in COVID-19 Pandemic E Karamitrousis, M Liontos, N Tsoukalas Forum of Clinical Oncology 11 (1), 1-2, 2020 | | 2020 |
| Cyclin-dependent kinase (CDK) 4/6 inhibitors in oncology E Karamitrousis, M Liontos, N Tsoukalas Forum of Clinical Oncology 10 (2), 1, 2019 | | 2019 |
| Mesothelioma E Karamitrousis, N Tsoukalas International Manual of Oncology Practice, 211-222, 2019 | | 2019 |
| Θρόμβωση και καρκίνος: εγχειρίδιο ενημέρωσης για ασθενείς και συνοδούς Ε Καραμητρούσης, Π Κολιού, Π Μπαξεβάνος, Α Μπόκας, Ν Τσουκαλάς, ... | | 2019 |
| Sorafenib, Ibritumomab tiuxetan Y-90, Dasatinib, Trifluridine/tipiracil V Karamitrousis, K Tsapakidis, P Ntellas, I Binas, N Tsoukalas New treatments in Oncology: manual for the management of adverse events, 2019 | | 2019 |
| Sorafenib, Ibritumomab tiuxetan Y-90, Dasatinib, Trifluridine/tipiracil Ε Καραμητρούσης, Κ Τσαπακίδης, Π Ντέλλας, Ι Μπίνας, Ν Τσουκαλάς Νεότερες Θεραπείες στην Ογκολογία: εγχειρίδιο ενημέρωσης ασθενών για τις …, 2019 | | 2019 |
EVI LianidouNATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENSVerified email at chem.uoa.gr
